Results 81 to 90 of about 44,621 (163)

Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment. [PDF]

Front Med (Lausanne), 2022
Delfanti G, Dellabona P, Casorati G, Fedeli M.   +3 more
europepmc   +1 more source

Nanoparticle-based modulation of CD4⁺ T cell effector and helper functions enhances adoptive immunotherapy. [PDF]

Nat Commun, 2022
Isser A, Silver AB, Pruitt HC, Mass M, Elias EH, Aihara G, Kang SS, Bachmann N, Chen YY, Leonard EK, Bieler JG, Chaisawangwong W, Choy J, Shannon SR, Gerecht S, Weber JS, Spangler JB, Schneck JP.   +17 more
europepmc   +1 more source

Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters. [PDF]

Front Immunol
Kennedy MG, Patterson W, Cox ST, Wynn L, Stock da Cunha C, O'Dwyer M, Danby R, Hernandez D.   +7 more
europepmc   +1 more source

TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer. [PDF]

Cell Rep Med, 2021
Beatson RE, Parente-Pereira AC, Halim L, Cozzetto D, Hull C, Whilding LM, Martinez O, Taylor CA, Obajdin J, Luu Hoang KN, Draper B, Iqbal A, Hardiman T, Zabinski T, Man F, de Rosales RTM, Xie J, Aswad F, Achkova D, Joseph CR, Ciprut S, Adami A, Roider HG, Hess-Stumpp H, Győrffy B, Quist J, Grigoriadis A, Sommer A, Tutt ANJ, Davies DM, Maher J.   +30 more
europepmc   +1 more source

Multivalent aptamer engineered and functionalized NK cells for enhanced adoptive immunotherapy in CD30-positive malignant lymphoma. [PDF]

Mol Ther Nucleic Acids
Tan F, Wei R, Su J, Sheng C, Li Q, Long Y, Zhao X, Zhao L, Huang S, Zhang L, Yang L, Zhang H, Yang S, Li H.   +13 more
europepmc   +1 more source

Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy. [PDF]

JCI Insight, 2022
Hu L, Chen L, Xiao Z, Zheng X, Chen Y, Xian N, Cho C, Luo L, Huang G, Chen L.   +9 more
europepmc   +1 more source

Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy. [PDF]

J Virol
Wu C, Johnson NM, Yu S, Lo AS, Sahu GK, Marx PA, von Laer D, Skowron G, Geleziunas R, Shaw GM, Kaur A, Junghans RP, Braun SE.   +12 more
europepmc   +1 more source

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. [PDF]

Cell Rep Med, 2023
Olivera I, Bolaños E, Gonzalez-Gomariz J, Hervas-Stubbs S, Mariño KV, Luri-Rey C, Etxeberria I, Cirella A, Egea J, Glez-Vaz J, Garasa S, Alvarez M, Eguren-Santamaria I, Guedan S, Sanmamed MF, Berraondo P, Rabinovich GA, Teijeira A, Melero I.   +18 more
europepmc   +1 more source

Advances in cancer immunotherapy: Strategies and innovations strategies for adoptive immunotherapy of cancer. [PDF]

Iran J Basic Med Sci
Moeinzadeh L, Mahmoudian-Sani MR, Purrahman D, Azghadi F, Darbandi MA.   +4 more
europepmc   +1 more source